Long COVID in 2025 reviews pathophysiology clinical management and the pharmacist role
Five years after the acute waves of COVID-19, Long COVID has settled into public health planning as a common post-infectious condition with sustained clinical, economic and social effects. The term describes persistent or fluctuating symptoms that follow SARS-CoV-2 infection and cannot be explained by an alternative diagnosis. Debate over wording has narrowed, yet definitions still […]